BB, MRVL, CMPS Stocks Hit 52-Week Highs Today: What’s Driving The Rally?

• BlackBerry and Nvidia expanded their partnership to integrate QNX OS with Nvidia’s IGX Thor platform.
• Google is reportedly working with Marvell to develop a memory processing unit and next-generation TPU.
• Compass Pathways saw a boost after a White House order expanded approval pathways for psychiatric treatments. 

BlackBerry (BB), Marvell Technology (MRVL), and Compass Pathways (CMPS) each surged to fresh 52-week highs on Monday as markets reacted to a wave of artificial intelligence infrastructure deals and a major shift in U.S. healthcare policy. 

The synchronized rally reflected growing investor enthusiasm for companies placed in the realm of advanced computing, robotics, safety systems, and mental health therapeutics.

BlackBerry’s QNX And NVIDIA Deepen AI Safety 

On Monday, BlackBerry and Nvidia Corp. (NVDA) expanded their collaboration to advance safety-critical artificial intelligence systems and unify real-time operating systems with high-performance AI compute. 

The companies said the initiative will merge QNX OS for Safety 8.0 with Nvidia’s IGX Thor platform and Halos Safety Stack to support next-generation edge AI deployments. The combined system is designed to serve robotics, medical imaging, surgical systems, and industrial automation. 

BlackBerry stock surged over 13%. Retail sentiment around the stock remained in ‘extremely bullish’ territory with message volume soaring over 1,500% in 24 hours. 

Marvell-Google Chip Partnership 

According to The Information’s report, Alphabet Inc. (GOOG, GOOGL) parent Google is in talks with Marvell to design both a memory-focused processing unit and a next-generation tensor processing unit intended specifically for AI model execution.

The proposed memory processing unit would work alongside Google’s existing tensor processing units, splitting AI workloads based on compute intensity and memory demands. The renewed collaboration with Marvell follows broader industry experimentation with multi-vendor inference chip strategies.

Marvell stock rose over 5%. Retail sentiment around the stock changed to ‘extremely bullish’ from ‘bullish’ territory the previous day, and message volume jumped 664% in 24 hours. 

White House Order Provides Lift To CMPS

Compass Pathways benefited from renewed optimism after the White House introduced an executive order designed to streamline research and regulatory pathways for psychiatric treatments.

President Donald Trump signed the directive on Saturday, instructing federal agencies to speed up evaluation processes for therapies targeting conditions such as depression, PTSD, and other complex psychiatric disorders.

The order calls on the Food and Drug Administration (FDA) to prioritize certain psychedelic candidates that have already shown early clinical promise.

Compass’ COMP360, a synthetic psilocybin therapy currently in late-stage clinical trials, has shown rapid symptom relief in patients with treatment-resistant depression, with effects emerging within a day and lasting up to several months after one or two doses.

Compass Pathways' stock surged 42%, with message volume up 1,095% on Stocktwits. 

So far this year, MRVL has surged 73%, while BB and CMPS have gained 45% and 37%, respectively. 

Also See: USAR Stock Climbs Overnight After 2 Analysts Turn Bullish On $2.8B Brazil Rare Earth Deal: Here's Their Domestic Supply Chain Thesis

For updates and corrections, email newsroom[at]stocktwits[dot]com.